Literature DB >> 25323818

Instability of depression severity at intake as a moderator of outcome in the treatment for major depressive disorder.

Sigal Zilcha-Mano1, Jacques P Barber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25323818      PMCID： PMC4423543          DOI： 10.1159/000365151

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  5 in total

1.  Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.

Authors:  E Frank; G B Cassano; P Rucci; W K Thompson; H C Kraemer; A Fagiolini; L Maggi; D J Kupfer; M K Shear; P R Houck; S Calugi; V J Grochocinski; P Scocco; J Buttenfield; R N Forgione
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

Authors:  Jacques P Barber; Marna S Barrett; Robert Gallop; Moira A Rynn; Karl Rickels
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

4.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

5.  Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

Authors:  André Tadić; Isabella Helmreich; Roland Mergl; Martin Hautzinger; Ralf Kohnen; Verena Henkel; Ulrich Hegerl
Journal:  J Affect Disord       Date:  2010-01       Impact factor: 4.839
  5 in total
  2 in total

1.  Therapeutic alliance in antidepressant treatment: cause or effect of symptomatic levels?

Authors:  Sigal Zilcha-Mano; Steven P Roose; Jacques P Barber; Bret R Rutherford
Journal:  Psychother Psychosom       Date:  2015-03-28       Impact factor: 17.659

2.  Accurate pain reporting training diminishes the placebo response: Results from a randomised, double-blind, crossover trial.

Authors:  Roi Treister; Oluwadolapo D Lawal; Jonathan D Shecter; Nevil Khurana; John Bothmer; Mark Field; Steven E Harte; Grant H Kruger; Nathaniel P Katz
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.